“…Once administered, therapeutic drugs should be in a concentration at which full efficacy is achieved with no associated side effects . For that purpose, several drug-delivery systems (DDS) have been formulated and/or are being investigated for drug administration (e.g., intravenous, oral, nasal). , Among them, metal–organic frameworks (MOFs) have recently emerged as original promising DDS. − MOFs are crystalline solids based on metal ions subunits coordinated to organic polydentate ligands, leading to the formation of highly porous structures . Their structural/chemical diversity and exceptional porosity (Brunauer–Emmett–Teller (BET) surface ( S BET ) up to 7000 m 2 ·g –1 ) together with their amphiphilic internal microenvironment are thus well adapted to the adsorption of a large variety of guest molecules, including the therapeutic ones (e.g., drugs, cosmetics, biological gases, enzymes). ,, …”